To Evaluate the Safety, Immunogenicity and Efficacy of GSK Biologicals' EBV Vaccine (268664) in Healthy Seronegative Adolescents/Adults When Injected Intramuscularly According to a 0-1-5 Month Schedule in Belgium.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2007
At a glance
- Drugs Epstein-Barr virus vaccine (Primary)
- Indications Infectious mononucleosis
- Focus Therapeutic Use
- 27 Feb 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History